Keith Richard O'brien, MD | |
2600 Main St Ste 119, Bridgeport, CT 06606-5305 | |
(203) 338-8760 | |
Not Available |
Full Name | Keith Richard O'brien |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 9 Years |
Location | 2600 Main St Ste 119, Bridgeport, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740667815 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 64924 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St. Vincent's Medical Center | Bridgeport, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Doctors worried about dangerous blood clots in patients undergoing a coronary artery procedure— such as angioplasty to treat a heart attack — will often administer antiplatelet therapy to head off complications.
A recent Research Scholar Grant from the American Cancer Society acknowledges the potential of Rensselaer researcher Lee Ligon's work on breast cancer. Ligon is investigating interactions between cells as breast cancer spreads within the body.
Using a cast is not more effective than a brace for treating broken ankles, according to University of Warwick researchers – a conclusion that could hasten the decline of the tradition of signing a cast.
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.
› Verified 4 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Doctors worried about dangerous blood clots in patients undergoing a coronary artery procedure— such as angioplasty to treat a heart attack — will often administer antiplatelet therapy to head off complications.
A recent Research Scholar Grant from the American Cancer Society acknowledges the potential of Rensselaer researcher Lee Ligon's work on breast cancer. Ligon is investigating interactions between cells as breast cancer spreads within the body.
Using a cast is not more effective than a brace for treating broken ankles, according to University of Warwick researchers – a conclusion that could hasten the decline of the tradition of signing a cast.
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Keith Richard O'brien, MD 2600 Main St Ste 119, Bridgeport, CT 06606-5305 Ph: (203) 338-8760 | Keith Richard O'brien, MD 2600 Main St Ste 119, Bridgeport, CT 06606-5305 Ph: (203) 338-8760 |
News Archive
Doctors worried about dangerous blood clots in patients undergoing a coronary artery procedure— such as angioplasty to treat a heart attack — will often administer antiplatelet therapy to head off complications.
A recent Research Scholar Grant from the American Cancer Society acknowledges the potential of Rensselaer researcher Lee Ligon's work on breast cancer. Ligon is investigating interactions between cells as breast cancer spreads within the body.
Using a cast is not more effective than a brace for treating broken ankles, according to University of Warwick researchers – a conclusion that could hasten the decline of the tradition of signing a cast.
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.
› Verified 4 days ago
Christine Wenyu Liaw, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2660 Main St Ste 117, Bridgeport, CT 06606 Phone: 203-338-8760 | |
Dr. Matthew Ryan Beamer, MD Urology Medicare: Medicare Enrolled Practice Location: 2660 Main St Ste 117, Bridgeport, CT 06606 Phone: 203-338-8760 Fax: 203-338-8765 | |
Dr. Milton Frank Armm, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3180 Main Street, Room 305, Bridgeport, CT 06606 Phone: 203-371-8651 Fax: 203-371-8930 | |
Mr. Jeffrey Daniel Small, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4695 Main St, Bridgeport, CT 06606 Phone: 203-372-4419 Fax: 203-372-4919 |